PDK3
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial
Also known as: PDK3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15120
- Gene
- PDK3
- Ensembl
- ENSG00000067992
- Chromosome
- X
- Canonical length
- 406 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle, and thus is one of the major enzymes responsible for the regulation of glucose metabolism. The enzymatic activity of PDH is regulated by a phosphorylation/dephosphorylation cycle, and phosphorylation results in inactivation of PDH. The protein encoded by this gene is one of the three pyruvate dehydrogenase kinases that inhibits the PDH complex by phosphorylation of the E1 alpha subunit. This gene is predominantly expressed in the heart and skeletal muscles. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
406 residues, UniProt reviewed canonical sequence.
>Q15120|PDK3
1 MRLFRWLLKQ PVPKQIERYS RFSPSPLSIK QFLDFGRDNA CEKTSYMFLR KELPVRLANT
61 MREVNLLPDN LLNRPSVGLV QSWYMQSFLE LLEYENKSPE DPQVLDNFLQ VLIKVRNRHN
121 DVVPTMAQGV IEYKEKFGFD PFISTNIQYF LDRFYTNRIS FRMLINQHTL LFGGDTNPVH
181 PKHIGSIDPT CNVADVVKDA YETAKMLCEQ YYLVAPELEV EEFNAKAPDK PIQVVYVPSH
241 LFHMLFELFK NSMRATVELY EDRKEGYPAV KTLVTLGKED LSIKISDLGG GVPLRKIDRL
301 FNYMYSTAPR PSLEPTRAAP LAGFGYGLPI SRLYARYFQG DLKLYSMEGV GTDAVIYLKA
361 LSSESFERLP VFNKSAWRHY KTTPEADDWS NPSSEPRDAS KYKAKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 34 nTPM
- salivary gland: 10 nTPM
- epididymis: 10 nTPM
- testis: 9 nTPM
- colon: 8.9 nTPM
- breast: 8.1 nTPM
Single-cell type
- sertoli cells: 335 nCPM
- lacrimal acinar cells: 262 nCPM
- neutrophils: 201 nCPM
- pancreatic islet cells: 180 nCPM
- neutrophil progenitors: 174 nCPM
- pituitary stem cells: 148 nCPM
Immune cell
- neutrophil: 57 nTPM
- eosinophil: 38 nTPM
- intermediate monocyte: 20 nTPM
- non-classical monocyte: 19 nTPM
- MAIT T-cell: 16 nTPM
- classical monocyte: 15 nTPM
Brain region
- hippocampal formation: 43 nTPM
- thalamus: 35 nTPM
- cerebral cortex: 32 nTPM
- basal ganglia: 28 nTPM
- white matter: 25 nTPM
- midbrain: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDK3.
Disease | AllUniProt
Conditions PDK3 is implicated in, by any mechanism.
- Charcot-Marie-Tooth disease, X-linked dominant, 6 (CMTX6) MIM:300905
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.45
- gnomAD missense Z
- 2.32
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to fatty acid
- cellular response to glucose stimulus
- hypoxia-inducible factor-1alpha signaling pathway
- peptidyl-serine phosphorylation
- peroxisome proliferator activated receptor signaling pathway
- regulation of glucose metabolic process
- regulation of pyruvate decarboxylation to acetyl-CoA
- regulation of reactive oxygen species metabolic process
Molecular functions
- ATP binding
- protein kinase activity
- protein serine/threonine kinase activity
- pyruvate dehydrogenase (acetyl-transferring) kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Histidine kinase/HSP90-like ATPase domain
- Histidine kinase domain
- Branched-chain alpha-ketoacid dehydrogenase kinase/Pyruvate dehydrogenase kinase, N-terminal
- Alpha-ketoacid/pyruvate dehydrogenase kinase, N-terminal domain superfamily
- Histidine kinase/HSP90-like ATPase superfamily
- PDK/BCKDK protein kinase
- Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase
- Mitochondrial branched-chain alpha-ketoacid dehydrogenase kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDK3 as an antibody target. Whether an autoantibody or antibody against PDK3 could matter depends on whether native PDK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDK3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...